LRRTM3 is dispensable for amyloid-β production in mice

Tiina Laakso1, Pranuthi Muggalla, Kai Kysenius

  • 1Neuroscience Center, University of Helsinki, Helsinki, Finland Institute of Biomedicine, University of Helsinki, Helsinki, Finland.

Insights

Leucine-rich repeat transmembrane 3 (LRRTM3) protein does not appear to regulate amyloid-beta (Aβ) production in adult or developing mice. Studies in LRRTM3-deficient mice found no significant differences in Aβ levels.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Neuronal LRRTM3 protein is implicated in amyloid-beta protein precursor (AβPP) processing.
  • LRRTM3 is considered a candidate gene for late-onset Alzheimer's disease.

Purpose of the Study:

  • To investigate the role of LRRTM3 in AβPP processing and amyloid-beta (Aβ) production in vivo.
  • To determine if LRRTM3 is essential for Aβ generation in both adult and developing mice.

Main Methods:

  • Analysis of amyloidogenic processing of AβPP in LRRTM3-deficient mice.
  • Comparison of Aβ and AβPP C-terminal fragment levels between different genotypes.
  • Assessment of Aβ levels in primary cortical neurons from mice with varying LRRTM3 expression.

Main Results:

  • No significant differences in Aβ or AβPP C-terminal fragment levels were observed between LRRTM3-deficient and control mice.
  • Aβ levels in primary cortical neurons were similar across genotypes, regardless of LRRTM3 presence.
  • LRRTM3 does not appear to be an essential regulator of Aβ production in adult mice.

Conclusions:

  • LRRTM3 is not required for Aβ generation in developing mice.
  • The study indicates LRRTM3 is not an essential regulator of Aβ production in vivo.
  • Further research may be needed to fully elucidate the role of LRRTM3 in neurological disorders.

Related Concept Videos